Share：
Share this content in WeChat
X
[Chinese][PDF]87282
• Clinical Article •
Value of different 3.0 T MRI sequences in diagnosis of subtype of renal cell carcinoma
MENG Qingcheng  XIA Weili  YAN Liangliang  LI Hailiang  QU Jinrong  ZHAO Erjiang 

Cite this article as: Meng QC, Xia WL, Yan LL, et al. Value of different 3.0 T MRI sequences in diagnosis of subtype of renal cell carcinoma. Chin J Magn Reson Imaging, 2019, 10(2): 140-144. DOI:10.12015/issn.1674-8034.2019.02.013.


[Abstract] Objective: To explore the clinical value of different MRI sequences in differenting the subtype of renal cell carcinoma, and to provide the imaging basis of making treatment plan and determining the prognosis of renal cell carcinoma.Materials and Methods: The clinical data of forty renal cell carcinoma patients proved by post-operation pathology were analyzed retrospectively in our hospital from March of 2014 to March of 2017, which were grouped as clear cell renal carcinoma group (21 cases) and no clear cell renal carcinoma group (19 cases, in which papillary cell type 11 cases, chromophobe cell type 8 cases). All the patients were checked with abdominal 3.0 T MRI and the sequences including routine scan, diffusion-weighted imaging and dynamic contrast enhancement. The occurrence rates of cystic degeneration, hemorrhage, necrosis and vein tumor emboli were statistical analysis, and the difference of apparent diffusion coefficient (ADC) value and tumor-cortical augmentation index in different time were also measured between two groups.Results: Compared with no clear cell renal carcinoma group, the occurrence rates of necrosis and cystic degeneration in clear cell renal carcinoma group were high, and the occurrence rates of hemorrhage were low, all which had significant difference (χ2=17.378, 5.414, 4.043, P=0.00, 0.020, 0.044), but the occurrence rate of vein tumor emboli between two groups was not significantly different (χ2=1.380, P=0.240). Area under the curve (AUC) of hemorrhage, necrosis, cystic degeneration and vein tumor emboli were 0.663, 0.828, 0.680 and 0.585; the ADC value of clear cell renal carcinoma was higher than that of no clear cell renal carcinoma, which was different significantly [(2.01±0.33)×10-3 mm2/s vs (1.49±0.13)×10-3 mm2/s, t=6.269, P=0.00]; the tumor-cortical augmentation index of clear cell renal carcinoma group in different stages were higher than those of no clear cell renal carcinoma (t=4.082, 6.059, 6.083, P=0.00, 0.00, 0.00), and the AUCs of tumor-cortical augmentation index in different phases were 0.817, 0.929 and 0.897 separately. The ADC values plus tumor-cortical augmentation index in nephrographic phase was 0.976, and the sensitivity was 0.976, specificity was 1.00.Conclusions: The sensitivity and specificity of ADC values plus tumor-cortical augmentation index were the highest in different 3.0 T MRI sequences, which had clinical reference value definitely.
[Keywords] renal cell carcinoma, subtype；magnetic resonce imaging；apparent diffusion coefficient

MENG Qingcheng Department of Radiology, Henan Tumor Hospital/Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou 450008, China

XIA Weili Department of Radiology, Henan Tumor Hospital/Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou 450008, China

YAN Liangliang Department of Radiology, Henan Tumor Hospital/Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou 450008, China

LI Hailiang* Department of Radiology, Henan Tumor Hospital/Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou 450008, China

QU Jinrong Department of Radiology, Henan Tumor Hospital/Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou 450008, China

ZHAO Erjiang Department of Medical Records Room, Henan Tumor Hospital/Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou 450008, China

*Correspondence to: Li HL, E-mail: Cjr.lihailiang@vip.163.com

Conflicts of interest   None.

Received  2018-05-27
Accepted  2018-09-21
DOI: 10.12015/issn.1674-8034.2019.02.013
Cite this article as: Meng QC, Xia WL, Yan LL, et al. Value of different 3.0 T MRI sequences in diagnosis of subtype of renal cell carcinoma. Chin J Magn Reson Imaging, 2019, 10(2): 140-144. DOI:10.12015/issn.1674-8034.2019.02.013.

[1]
Beck SD, Patel MI, Snyder ME, et al. Effect of papillary and chromophobe celltype on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol, 2004, 11(1): 71-77.
[2]
Erbay G, Koc Z, Karadeli E, et al. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values. Acta Radiol, 2012, 53(3): 359-365.
[3]
邢征宇，高阳．动态对比增强磁共振成像在肾癌中的研究进展．磁共振成像, 2015, 6(12): 957-960.
[4]
Wang H, Zhang X, Ye H. Applications of diffusion-weighted magnetic resonance imaging in renal cell carcinoma. Expert Rev Anticancer Ther, 2011, 11(7): 1017-1022.
[5]
Goyal A, Sharma R, Bhalla AS, et al. Diffusion-weighted MRI in inflammatory renal lesions: all that glitters is not RCC. Eur Radiol, 2013, 23(1): 272-279.
[6]
Sun MR, Ngo L, Genega EM, et al. Renal cell carcinoma dynamic contract-enhanced MR imaging for differentiation of tumor subtypes-correlation With pathological findings. Radiology, 2009, 250(3): 793-802．
[7]
Prasad SR, Humphrey PA, Catena JR, et al. Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics, 2006, 26(6): 1795-1806．
[8]
Chen J, Sun J, Xing W, et al. Prediction of nuclear grade of clear cell renal cell carcinoma with MRI: intratumoral susceptibility signal intensity versus necrosis. Acta Radiol, 2014, 55(3): 378-384.
[9]
Gurel S, Narra V, Elsayes KM, et al. Subtypes of renal cell carcinoma: MRI and pathological features. Diagn Interv Radiol, 2013, 19(4): 304-311.
[10]
Beddy P, Genega EM, Ngo L, et al. Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma. Clin Genitourin Cancer, 2014, 12(1): 55-62.
[11]
Takeuchi M, Urano M, Hara M, et al. Characteristic MRI findings of sarcomatoid renal cell carcinoma dedifferentiated from clear cell renal carcinoma: radiological-pathological correlation. Clin Imaging, 2013, 37(5): 908-912.
[12]
Egbert ND, Caoili EM, Cohan RH, et al. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR Am J Roentgenol, 2013, 201(2): 347-355.
[13]
Rosenkrantz AB, Sekhar A, Genega EM, et al. Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma. Eur Radiol, 2013, 23(2): 579-587.
[14]
Vargas HA, Delaney HG, Delappe EM, et al. Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. J Magn Reson Imaging, 2013, 37(5): 1160-1167.
[15]
Kim JH, Bae JH, Lee KW, et al. Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging. Urology, 2012, 80(4): 872-876.
[16]
Rosenkrantz AB, Niver BE, Fitzgerald EF, et al. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol, 2010, 195(5): 344-351.
[17]
Yu X, Lin M, Ouyang H, et al. Application of ADC measurement in characterization of renal cell carcinomas with different pathological types and grades by 3.0 T diffusion-weighted MRI. Eur J Radiol, 2012, 81(11): 3061-3066.
[18]
Goyal A, Sharma R, Bhalla AS, et al. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype. Acta Radiol, 2012, 53(3): 349-358.
[19]
Notohamiprodjo M, Staehler M, Steiner N, et al. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma. Acad Radiol, 2013, 20(6): 685-693.

PREV MRI differentiation between breast mucinous carcinoma and fibroadenoma
NEXT Prediction of lymph vascular space invasion in cervical squamous cell carcinoma by using volumetric dynamic contrast-enhanced MRI
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn